BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

IN3BIO gains approval for Phase I/II clinical trial

IN3BIO will trial its innovative anti-EGF vaccine IN01, in combination with small molecule inhibitors (SMIs) in patients suffering from KRAS or NRAS (...

June 10, 2021 | News

NUS researchers develop world’s first blood test for real-time monitoring of cancer treatment success

Cancer patients who are undergoing targeted therapy can look forward to a new blood test that could tell their doctors whether the treatment is working, wi...

June 10, 2021 | News

China Pharma to Launch Highly Purified NMN+PQQ Product

NMN is a natural compound found in the human body and is constantly being metabolized. It is also found in trace amounts in certain foods. NMN serves as a ...

June 10, 2021 | News

Cytiva opens experience and learning lab in Singapore

New lab will support Singapore government’s Industry 4.0 agenda to build research, digital, innovation capability and talent development Part of C...

June 08, 2021 | News

Innovative Mass Spectrometer Designed for Small Molecule Analysis

Small molecule researchers in academia, pharmaceutical, and biopharmaceutical industries can now use a new, intelligent mass spectrometer (MS) to reveal co...

June 08, 2021 | News

Elekta's new strategy to focus on growth and access to radiation therapy

At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, Gustaf Salford, and members from his executive management team introduced the company's mid-term str...

June 08, 2021 | News

Australian researchers lead world in successful trial of new cancer treatment

Relatlimab is the first immunotherapy treatment to target LAG-3, a protein in immune cells which reinvigorates and enhances the tumour fighting r...

June 07, 2021 | News

Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™

ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...

June 07, 2021 | News

Vela Diagnostics Collaboration with the NCCS to Refine Novel Cancer Therapy

Being able to predict an individual's response will help clinicians determine if EGFR-TKIs are a suitable therapeutic option for the patient. The partnersh...

June 04, 2021 | News

Akoya launches Advanced Biopharma Solutions

Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced the launch of Advanced Biopharma Solutions (ABS) as a premium serv...

June 03, 2021 | News

Liminal BioSciences Update Clinical Activities for Fezagepras

Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...

May 31, 2021 | News

Eisai to Present Data on Oncology Pipeline and Products

At this meeting, there will be an oral presentation on the analysis of health-related quality-of-life (HRQoL) (Abstract No: 4502) of the pivotal Phase 3 CL...

May 20, 2021 | News

Nanoform’s final clinical results confirm value proposition to the pharma industry

Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical s...

May 18, 2021 | News

Scientific studies by researchers in Singapore on the efficacy of COVID-19 mitigation measures

A*STAR has worked together with the local research ecosystem , including Temasek Foundation, Temasek Life Sciences Laboratory, Institutes of High...

May 18, 2021 | News

Stay Connected